Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Chlorhexidine digluconate solution

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 28 USDMF, 9 CEP/COS, 8 JDMF, 6 EU WC, 1 KDMF, 1 VMF, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

53 Drugs in Development

53 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

275 FDF Dossiers, 49 FDA Orange Book, 125 Europe, 69 Canada, 11 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 4 SPI Pharma, 14 DKSH, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 10 Kirsch Pharma, 4 ACG Worldwide, 18 Actylis, 1 Ashland, 23 BASF, 2 BioSpectra, 4 CD Formulation, 1 Clariant, 6 Corel Pharma Chem, 1 Esteem Industries, 4 Finar, 5 Gangwal Chemicals, 1 Ideal Cures, 3 Kerry, 1 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

53 Topical, 38 Thickeners and Stabilizers, 37 Parenteral, 36 Solubilizers, 21 Coating Systems & Additives, 20 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 14 Rheology Modifiers, 13 Surfactant & Foaming Agents, 11 Controlled & Modified Release, 10 Taste Masking, 10 Emulsifying Agents, 8 Empty Capsules, 6 Co-Processed Excipients, 5 Direct Compression, 4 API Stability Enhancers, 4 Granulation, 4 Chewable & Orodispersible Aids, 4 Lubricants & Glidants, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 23 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

34 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 US Exclusivities

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
16/12/2025	R N Laboratories	India	Pharmasol Co., Ltd.	20251105-211-J-2055	Chlorhexidine Gluconate	2025-11-05	RNLABORATORIES PVT.LTD	India	Plot No 1 & 86, Special Economic Zone, Sachin, Surat, Gujarat, India

Chlorhexidine Digluconate Solution

Chlorhexidine digluconate solution

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers

28 USDMF

9 CEP/COS

8 JDMF

6 EU WC

1 KDMF

1 VMF

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

275 FDF Dossiers

49 FDA Orange Book

125 Europe

69 Canada

11 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%

SOLUTION;TOPICAL - 2%

TABLET;DENTAL - 2.5MG

SOLUTION;TOPICAL - 2%;70%

SPONGE;TOPICAL - 2%;70% (1.5ML)

SPONGE;TOPICAL - 2%;70% (10.5ML)

SPONGE;TOPICAL - 2%;70% (1ML)

SPONGE;TOPICAL - 2%;70% (26ML)

SPONGE;TOPICAL - 2%;70% (3ML)

SOLUTION;TOPICAL - 61%;1%

SWAB;TOPICAL - 3.15%;70% (1.6ML)

SWAB;TOPICAL - 3.15%;70% (1ML)

SWAB;TOPICAL - 3.15%;70% (5.1ML)

SWAB;TOPICAL - 2%;70% (0.67ML)

SWAB;TOPICAL - 2%;70% (1.75ML)

SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

4 SPI Pharma

14 DKSH

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Pfanstiehl

10 Kirsch Pharma

4 ACG Worldwide

18 Actylis

1 Ashland

23 BASF

2 BioSpectra

4 CD Formulation

1 Clariant

6 Corel Pharma Chem

1 Esteem Industries

4 Finar

5 Gangwal Chemicals

1 Ideal Cures

3 Kerry

1 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

1 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pluviaendo

1 Qualicaps